BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abrignani MG, Lombardo A, Braschi A, Renda N, Abrignani V. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view. World J Cardiol 2023; 15(8): 375-394 [PMID: 37771340 DOI: 10.4330/wjc.v15.i8.375]
URL: https://www.wjgnet.com/1007-9327/full/v15/i8/375.htm
Number Citing Articles
1
AN Patnaik. Is It Time to Say No to Proton-Pump Inhibitors to Cardiac Patients?Indian Journal of Clinical Cardiology 2024; 5(3): 227 doi: 10.1177/26324636241257762
2
Andreana Foresta, Luisa Ojeda Fernandez, Ginevra Torrigiani, Simone Schena, Maria Carla Roncaglioni, Alessandro Nobili, Mauro Tettamanti, Carlotta Franchi, Ida Fortino, Elena Succurro, Giorgio Sesti, Marta Baviera. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort StudyDrugs & Aging 2024; 41(3): 239 doi: 10.1007/s40266-024-01097-x
3
Georges Jourdi, Jean-Sébastien Hulot, Pascale Gaussem. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?Expert Opinion on Drug Metabolism & Toxicology 2024; 20(8): 749 doi: 10.1080/17425255.2024.2378888